Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer: Can an Agnostic Become a Believer?
J Clin Oncol
.
2020 Feb 10;38(5):381-383.
doi: 10.1200/JCO.19.02921.
Epub 2019 Dec 26.
Author
Susan F Slovin
1
Affiliation
1
Memorial Sloan Kettering Cancer Center, New York, NY.
PMID:
31877088
DOI:
10.1200/JCO.19.02921
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
Humans
Male
Prostatic Neoplasms, Castration-Resistant*
Substances
Antibodies, Monoclonal, Humanized
pembrolizumab